Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumors (Phase 1)”

5,301 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,301 results

Early research (Phase 1)UnknownNCT05302843
What this trial is testing

BPI-28592 in Subjects With Advanced Solid Tumors

Who this might be right for
Metastasis, Neoplasm
Betta Pharmaceuticals Co., Ltd. 40
Early research (Phase 1)Study completedNCT01051635
What this trial is testing

A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas

Who this might be right for
NeoplasmsLymphoma
National Cancer Institute (NCI) 55
Early research (Phase 1)Study completedNCT01517464
What this trial is testing

A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors

Who this might be right for
Neoplasm
SynerGene Therapeutics, Inc. 13
Early research (Phase 1)Ended earlyNCT04835714
What this trial is testing

Find a Safe and Effective Dose of BI 1701963 Alone and in Combination With BI 3011441 in Patients With Advanced Cancer and a Certain Mutation (Kirsten Rat Sarcoma Viral Oncogene Homologue [KRAS])

Who this might be right for
Solid Tumors, KRAS Mutation
Boehringer Ingelheim 8
Early research (Phase 1)Study completedNCT04330664
What this trial is testing

Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 86
Early research (Phase 1)Study completedNCT01919398
What this trial is testing

LY2940680 in Japanese Participants With Advanced Cancers

Who this might be right for
Neoplasm Metastasis
Eli Lilly and Company 19
Testing effectiveness (Phase 2)Looking for participantsNCT05970016
What this trial is testing

A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.

Who this might be right for
Patients with Advanced Solid Tumors
Beijing Tide Pharmaceutical Co., Ltd 56
Testing effectiveness (Phase 2)Study completedNCT02113800
What this trial is testing

Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study

Who this might be right for
Poorly Differentiated Malignant Neuroendocrine CarcinomaNeuroendocrine Carcinoma, Grade 3Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3+2 more
AIO-Studien-gGmbH
Early research (Phase 1)Study completedNCT00503204
What this trial is testing

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Who this might be right for
Recurrent GlioblastomaBrain Tumor
AstraZeneca 20
Early research (Phase 1)Study completedNCT03133247
What this trial is testing

A Trial to Evaluate Safety and Tolerability of SHR-1316 in Cancer Patients

Who this might be right for
Advanced Solid Tumors
Atridia Pty Ltd. 37
Early research (Phase 1)Study completedNCT02223247
What this trial is testing

A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors

Who this might be right for
Solid Malignant Tumor
Sagimet Biosciences Inc. 180
Early research (Phase 1)Temporarily pausedNCT02354547
What this trial is testing

SGT-53 in Children With Refractory or Recurrent Solid Tumors

Who this might be right for
Neoplasm
SynerGene Therapeutics, Inc. 18
Early research (Phase 1)Study completedNCT00165802
What this trial is testing

A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid Tumors

Who this might be right for
Cancer, Malignant Tumors
Eisai Inc. 40
Early research (Phase 1)Active Not RecruitingNCT05614102
What this trial is testing

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bayer 284
Testing effectiveness (Phase 2)Study completedNCT00526045
What this trial is testing

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

Who this might be right for
Breast CancerHematologic Neoplasms
Novartis Pharmaceuticals 117
Testing effectiveness (Phase 2)Active Not RecruitingNCT04902872
What this trial is testing

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
Solid Tumor, AdultEpithelial Ovarian CancerSmall Cell Lung Carcinoma+9 more
Cybrexa Therapeutics 130
Early research (Phase 1)Ended earlyNCT01378377
What this trial is testing

Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus

Who this might be right for
Advanced Solid Tumor
EMD Serono 33
Early research (Phase 1)Study completedNCT03077607
What this trial is testing

Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Pfizer 36
Early research (Phase 1)Study completedNCT00003207
What this trial is testing

Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers

Who this might be right for
SarcomaUnspecified Adult Solid Tumor, Protocol Specific
Washington University School of Medicine 14
Early research (Phase 1)Study completedNCT04094506
What this trial is testing

Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
Astellas Pharma Inc 9
Load More Results
40